Melissa Brouwers is an Associate Professor and Health Services Research Lead in the Department of Oncology, McMaster University; Provincial Director of the Program in Evidence-based Care, Cancer Care Ontario; National Lead for the Capacity Enhancement Project of the Canadian Partnership Against Cancer; and KT Lead for The Canadian Centre for Applied Research in Cancer Control (ARCC).
Dr. Brouwers holds a BSc in Psychology from the University of Toronto and an MA and PhD in Psychology from the University of Western Ontario. She is an active and leading member of various national and international research groups including a member of the Clinical Guidelines (CG) Action Group of the Canadian Partnership Against Cancer, and the Lead of the AGREE Research Enterprise (Principal Investigator of AGREE Next Steps Project, upcoming AGREE A3 Project and the AGREE Research Trust).
Public Health, the University of British Columbia, is an internationally known health services researcher for her work delineating the social context of health seeking behaviour and the evaluation of health systems. Her work is in cross-cultural cancer care, from prevention to palliation, and psychosocial oncology. As the scientific lead and Co-PI on two CIHR-funded survivorship initiatives: the New Emerging Team for Palliative Care in Cross Cultural Context: A NET for Equitable and Quality Cancer Care for Culturally Diverse and the CIHR Team for Supportive Cancer Care, her work is focused on the development of tools, empirical and conceptual, used to frame research questions pertaining to survivorship, vulnerable populations, and access to appropriate and quality cancer care. Her work also includes the development of a Knowledge Exchange – Decision Support (KE-DS) Model and Toolkit which is now being applied in a number of supportive cancer care projects.
Mary McBride is an epidemiologist, health services researcher, and Distinguished Research Scientist in the Cancer Control Research Department of the BC Cancer Agency. She is also Clinical Professor in the School of Population and Public Health and member of the Department of Pediatrics, University of British Columbia. Mary oversees two research programs investigating late effects and health care issues post-treatment for young people diagnosed with cancer, and women diagnosed with breast cancer, using research platforms developed by linking person-specific, longitudinal, population-based registries and clinical and administrative databases. She is also a co-investigator in a recently-funded CIHR Team Grant on gaps and coordination in oncology and primary care for cancer patients across the care trajectory, from pre-diagnosis to end-of-life. She has also led and contributed to research on the causes of childhood cancer, and the relationship between non-ionizing electromagnetic fields (ELF-EMF and RF) and cancer, in Canada, the US, Europe, and for the World Health Organization.
Morris L. Barer is a Professor and Co-Lead, Health Care Services and Systems, in the new School of Population and Public Health at the University of British Columbia (UBC). He also is (and was the founding) Director of the Centre for Health Services and Policy Research at UBC. From December 2000 to August 2006, he served as the first Scientific Director of the Institute of Health Services and Policy Research, Canadian Institutes of Health Research. During that time, he played leadership roles in the establishment of the Canadian Association for Health Services and Policy Research (CAHSPR), and the Canadian journal Healthcare Policy, first published in 2005.
Dr. Barer’s research interests include healthcare financing, health human resource policy (particularly physicians), direct-to-consumer advertising of prescription pharmaceuticals, and the determinants of changing trends in healthcare utilization.
Shawn Bugden is an Associate Professor of Pharmacy at the University of Manitoba, Faculty of Pharmacy. His research interests include pharmacoeconomics/outcomes, drug evaluation and knowledge translation. He has a long history of involvement with the Community Care Program Network (CCPN) and CancerCare Manitoba. He currently provides support in pharmacoeconomic assessment for the Manitoba Provincial Oncology Drug Program. Since 2003, he has also worked as a drug evaluation pharmacist with PrISM (Prescription Information Services of Manitoba) and their work in academic detailing with the Canadian Academic Detailing Collaboration. Shawn has completed a Master of Science in Evidence Based Health Care from the University of Oxford and taken further post-graduate training at the University of Manitoba, and the University of Washington.
Hsien Seow holds McMaster University’s Cancer Care Ontario Research Chair in Health Services Research in the Department of Oncology. His PhD is from Johns Hopkins School of Public Health, Department of Health Policy and Management, with a concentration in health services research and a certificate in Gerontology. His research interests involve examining ways to better coordinate, organize and deliver healthcare services and improve quality for those with serious, chronic illness. He has worked with RAND Health in Washington DC, where he led health policy research, quality improvement, and health advocacy initiatives. He earned a B.Sc from Yale University.
Jaclyn completed her BSc (Honours) in biology and her MSc in health services research at the University of Toronto. She works closely with policy-makers, clinicians and researchers to develop and evaluate pharmacoeconomic analyses for new cancer therapies. Her research interests include economic evaluation of cancer screening and treatment interventions with Markov models, the role of pharmacoeconomic evidence in reimbursement decision-making, and KTE for health economic methods and findings.
Sonya is a research scientist and her research interests lie in the appraisal of biomedical innovation, optimized public health and the efficient use of healthcare resources. She holds a Bachelor of Science from the University of Victoria, a PhD from the University of British Columbia and a Masters in Business Administration from Simon Fraser University.
Wanrudee Isaranuwatchai is a health economist and manager of the Centre for exceLlence in Economic Analysis Research (CLEAR). She received her PhD in Health Services Research from the Institute of Health Policy, Management and Evaluation at the University of Toronto. She also holds a Bachelor of Science in Health Studies and Gerontology from the University of Waterloo.
Dr. Isaranuwatchai has experience conducting economic evaluations using decision modeling and patient-level data. Her research interests include health economics, economic evaluations, cancer research, disaster, mental health, and quantitative research methods. Dr. Isaranuwatchai is committed to promoting the use of evidence in health care decision making.
As a health economist, Helen is conducting research in the areas of quality of life and instrument development. Among other projects, she is currently involved in an international project that aims to construct multi-attribute preference-based measures for use in the economic evaluation of cancer therapies. Helen received her MSc from the Department of Health Care and Epidemiology at UBC and her PhD from the School of Health and Related Research at the University of Sheffield. Her research interests include preference elicitation techniques, discrete choice experiments, health state development, and informed general population valuations.
Linda Rozmovits received her DPhil from the University of Sussex and specializes in qualitative health research. Initially trained in qualitative methodology at the Institute of Health Sciences, Oxford University, she has worked with scores of academic, clinical and community-based research teams in the UK and Canada. While her research portfolio is very broad, Linda has a strong background in cancer services and colorectal cancer in particular. Other areas of interest include patient and carer needs and experiences, quality improvement initiatives and health equity issues. Over the past few years, Linda has developed and delivered qualitative methods training for clinicians and other quantitatively-trained scientists and champions the use of qualitative methods in health services research.
Dr. Bansback’s research seeks to inform policies and practices in health through the application of health economics and decision theory. His methodological research in measuring and valuing health, economic evaluation and network meta-analysis have been applied to a wide range of applications from informing policy makers on resource allocations decisions, to patients making treatment choices. His ARCC funded research has focused on helping patients make better treatment choices through novel decision tools, and risk surveys.
Helena Daudt is the Clinical Research Manager at the BC Cancer Agency – Vancouver Island Centre (VIC), Adjunct Assistant Professor – Faculty of Human and Social Development at University of Victoria and a research leader in the area of supportive care. Dr. Daudt is a Biologist with training in Education and a PhD in Toxicology from Simon Fraser University. She joined BCCA in 2008 and shifted her research interests to cancer supportive care with an emphasis on health education, health promotion and knowledge translation. Dr Daudt is particularly interested in understanding the information needs of people living with cancer and how to address those needs to improve people’s quality of life and well-being. She is a member of the BC Cancer Agency Provincial Survivorship Program Steering Committee and was actively engaged in the development of the program’s current strategic plan.
Dr. Fillion is a Full Professor in Nursing Sciences at Laval University, Quebec City and an Adjunct Professor in Psychology at Montreal University, Montreal, Quebec. She is also a researcher at the Cancer Research Center at Laval University and a member of the Michel Sarrazin Psychosocial Oncology and Palliative Care Research Team (ERMOS). She is the scientific director of the CHUQ Nursing Research Unit (URSI-CHUQ), and a member of the CHUQ Research Center – cancer division steering committee (CRCHUQ-axe cancer). She works as a psychologist with the Psychosocial and Spiritual Oncology team at the CHUQ. She has received grants from the FRSQ (Fond de recherche en santé du Québec), the Canadian Cancer Society (CCS), the Canadian Cancer Society Research Institute (CCSRI), the Ministère de la Santé et des Services Sociaux (MSSS), the Canadian Health Services Research Foundation (CHSRF), the Canadian Institute of Health Research (CIHR), the Institut de recherche en santé et en sécurité au travail (IRSST), the ASSS-03, and the Canadian Partnership Against Cancer (CPAC). Dr. Fillion’s area of expertise is cancer survivorship and palliative care. More specifically, her interests include psychological stress, psychosocial adaptation to cancer, methodological aspect of the measurement of stress and of the adaptation to cancer, coping, symptoms management (stress, fatigue, pain), satisfaction and meaning at work in health care providers, models of care, and professional navigation in oncology.
Dr. Jennifer Jones is the Director of Research for the Cancer Survivorship Program, Associate Director of the Centre for Health Wellness and Cancer Survivorship (ELLICSR) and a Research Associate in the Department of Psychosocial Oncology and Palliative Care at Princess Margaret Hospital. In addition, she is an Assistant Professor in the Department of Psychiatry, at University of Toronto.
Dr. Jones’ research program has primarily focused on psychosocial factors among the medically ill. This has included the assessment of symptoms and quality of life at the end of life and the use of proxy assessments. More recently, through her work within the newly developed Cancer Survivorship Program at Princess Margaret Hospital (PMH),her research interests have included: 1) assessing the prevalence and impact of long-term and late effects of cancer and its treatment (i.e. fatigue, bone loss) and psychosocial distress in cancer survivors; 2) the development and evaluation of group and individual psychoeducational interventions to promote patient engagement in self-management activities and to support families affected by cancer; 3) evaluation of new innovative models of care delivery. She has also developed expertise in the area of continuing education and professional development and knowledge translation.
Dr. Marshall is an Associate Professor in the Department of Community Health Sciences, University of Calgary and the Director of Health Technology Assessment (HTA) at the Alberta Bone and Joint Health Institute and Associate Professor (part-time) in the Department of Clinical Epidemiology and Biostatistics at the Centre for Evaluation of Medicines at McMaster University. Her Canada Research Chair, Health Services and Systems Research is a HTA research programme involving synthesis of evidence, measurement of preferences, cost-effectiveness analysis, and decision modeling of health systems. Dr. Marshall has research experience in HTA agencies, academic institutions and industry settings in Canada, US and Europe. Dr. Marshall’s academic training includes a PhD from the School of Public Health at the University of North Carolina, Chapel Hill as an Alberta Heritage Foundation for Medical Research Scholar, an MSc in Health Services Research (University of Alberta) and a BSc in Biochemistry (University of Toronto).
Her peer-reviewed cancer research grants from the US National Institutes of Health / National Cancer Institute and the Ontario Institute for Cancer Research are focused in the areas of measuring patient preferences using conjoint analysis, personalized medicine, and cost-effectiveness modeling. She is a Project Leader of the Economics Project in the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS – clinicalpharmacy.ucsf.edu/transpers), dedicated to developing evidence-based information for patients and other stakeholders to objectively assess how personalized medicine can be most beneficial and efficient in improving health outcomes.
Dr. Marshall is an active member of the International Society for Pharmacoeconomics and Outcomes Research as a member of the Patient Preferences Special Interest Group and as President-Elect member of the Board of Directors. She was also a member of the CADTH/NCIC Working Group to develop cancer-specific economic evaluation guidelines, and the NCI Clinical Trials and Translational Research Advisory Board Cost-Effectiveness Analysis Working Group. She also serves on the editorial board of the International Journal for Technology Assessment in Health Care and The Patient.
Dr. Baukje (Bo) Miedema is professor of Family Medicine and Director of Research at the Dalhousie University Family Medicine Teaching Unit in Fredericton. She has trained as a general and psychiatric nurse in Holland before she earned her PhD in Sociology at the University of New Brunswick. Over the years she has developed a robust program of research in cancer survivorship including cancer follow-up care and rehabilitation issues. Bo has received provincial, regional and national grants (CIHR & SSHRC) as principal investigator and as co-investigator to support her research endeavors. She has published extensively with more than 50 peer reviewed papers and three books as author or editor. She has strong working relationships nationally and internationally by being involved in various professional organizations related to cancer in primary care. Bo is a non-physician member of the College of Family Physicians of Canada and has served as a member of the Section of Researchers of the College. Further, she serves as a reviewer for many national and international journals and granting agencies. In her spare time she is President of the Board of Directors of the Multicultural Association of Fredericton (MCAF). MCAF provides a broad range of services to the newcomer community in Fredericton and has a workforce of around 50 part-time and full-time employees.
Jason D. Pole
Dr. Jason Pole is Scientist with the Pediatric Oncology Group of Ontario (POGO) and is an Assistant Professor in the Dalla Lana School of Public Health, University of Toronto and an Adjunct Scientist with the Hospital for Sick Children Research Institute and the Institute for Clinical Evaluative Sciences, Toronto. Jason has a background in epidemiology and health services research with an emphasis in the use of administrative data and complex survey instruments. Jason has research interests in the areas of health care utilization among childhood cancer survivors, the effects of childhood cancer treatment specifically on the development of second cancers and education achievement and has interests in the financial impact of a childhood cancer diagnosis on the family and the long-term financial health of the survivor.
Dr. Wranik is a health economist, whose research is focused on three broad topics, all related to efficient and evidence supported health policies and health policy decisions. The first of the three topics is the improved understanding of decision making processes in the approval of services or drugs for public funding, and specifically the actual and potential role played by economic evidence. The second is an aggregate assessment of health system efficiencies using frontier methods, along with an investigation into the policy tools that are associated with more efficient systems. The third is a focus on physician payments as one of the policy levers that can be used to improve efficiencies in the system.
Since 2006, Dr. Wranik has served as a health economist on the Nova Scotia Systemic Cancer Therapy Committee, which offers advice to the Minister with respect to the funding of new cancer drugs and therapies. Her work consists of the analysis and interpretation of economic evidence that is provided by the industry in support of their submissions. It is here where Dr. Wranik’s interest was sparked in the misalignment of the use and the production of cost-utility analyses. She has identified a need for a framework for decision making processes that gives clear guidance to both health economists and decision makers.
Dr. Wranik teaches graduate courses in health economics, managerial economics and program evaluation at the School of Public Administration at Dalhousie University.
Sarah Benn was the previous Network Manager for the Canadian Centre for Applied Research in Cancer Control (ARCC). Sarah brought to ARCC strong communication and relationship-building skills, from her experience working with a number of interdisciplinary and inter-professional groups. Sarah received her Master of Arts degree in Health and Aging from McMaster University. She also holds a Bachelor of Arts, Honours Sociology from Bishop’s University.
Stirling Bryan is Director of the Centre for Clinical Epidemiology & Evaluation, and full professor in the School of Population & Public Health at UBC. He is also honorary professor at the University of Birmingham (UK), an Associate of the UBC Centre for Health Services & Policy Research and an Adjunct Associate at the Center for Health Policy at Stanford University. In 2005/06 Stirling was a Commonwealth Fund Harkness Fellow in Health Care Policy, based at Stanford. He sits on the UK Medical Research Council’s College of Experts, the Scientific Committee of the International Health Economics Association and the Editorial Board of Health Economics, a journal for which he is also an Associate Editor. Dr Bryan’s research interests span the areas of economic evaluation and health technology assessment from applied and methodological perspectives, including preference elicitation and outcome measurement, and the use of economic analyses in decision-making. England.
Richard Doll is Director of the Sociobehavioural Research Centre and the Provincial Leader for Cancer Rehabilitation at the British Columbia Cancer Agency. His responsibilities include implementing supportive care programs within BCCA and promoting the development of community based programs. He is a member of CIHR Advisory Board for the Institute of Cancer Research, a member of the Rebalance Focus Action Group (RF) for the Canadian Strategy for Cancer Control (CSCC), a co-chair of the Rehabilitation and Survivorship Study Group for the Multinational Association Supportive Care in Cancer, and a founding member of the Canadian Association of Psychosocial Oncology. Richard co-leads a new and emerging team for palliative care in the cross cultural context.
Research interests also include health technology and access to care.
Konrad Fassbender completed an interdisciplinary PhD in Health Economics at the University of Alberta, and was awarded the Charles WB Gravett Memorial Scholarship for superior academic achievement in healthcare planning and evaluation. Health Canada recognized his doctoral work in home care by hosting provincial/territorial roundtables examining his economic models. Dr. Fassbender’s work has been cited by the Mazankowski and Kirby reports on healthcare reform. He served/s in advisory roles to the OECD (Organization for Economic Co-ordination and Development), CIHR (Canadian Institute of Health Research), AHW (Alberta Health and Wellness) and Health Canada.
Dr. Fassbender supervises graduate students and teaches health economics, health finance and econometrics. He has developed tools to measure the cost and performance associated with the financing and delivery of health and social services. These tools have since been adapted to the study of low-income families, injury, families of disabled children and rehabilitation.
His program of research is to study the effects of health reform and technological change on health and economic outcomes of dying patients and their families.
Bart Harvey is an Associate Professor at the University of Toronto where he serves as the Head of the Dalla Lana School of Public Health’s Interdisciplinary Division, as the Department of Family & Community Medicine’s Public Health Liaison, and as the Undergraduate Medical Program’s Director of Program Evaluation. He is a past President of the Canadian National Specialty Society for Community Medicine, the current Chair of the Royal College of Physician and Surgeons of Canada’s Specialty Committee for Community Medicine, and a member of the Board of the American College of Preventive Medicine.
Dr. Harvey teaches undergraduate epidemiology and statistics courses at the University of Toronto and is the principal or a co-investigator on several externally-funded research and/or education initiatives. He has authored or co-authored more than 30 papers published in peer-reviewed biomedical journals, and has presented at national and international scientific conferences. In 2006 he received the American Medical Writers Association’s Golden Apple Award for excellence in teaching, and this year was awarded a Fellowship by the Association.
David C. Hodgson is an Associate Professor and clinician scientist in the Department of Radiation Oncology, and the Department of Health Policy, Management and Evaluation at the University of Toronto. He is a staff radiation oncologist at the Princess Margaret Hospital, and an Adjunct Scientist at the Institute for Clinical Evaluative Sciences in Toronto.
He received his medical degree and radiation oncology training at the University of Toronto and a Masters degree in Public Health from Harvard University.
Dr. Hodgson’s research activities include technology assessment and the use of population-based health administrative data to evaluate the treatment and outcome of cancer patients. He has received peer-reviewed funding from the Canadian Institutes for Health Research, the National Cancer Institute of Canada and Cancer Care Ontario.
Louis Lemieux-Charles is Chair of the Department of Health Policy, Management and Evaluation (HPME), University of Toronto. She also is an Associate Professor in HPME, Program Director of the Hospital Management Research Unit, an adjunct scientist with the Institute for Work and Health, and a member of the Collaborative Centre for Bioethics at the University. Previously, she held positions in senior management in the acute care system, in teaching and in consulting. She is actively involved in both the MHSc and the MSc/PhD programs as teacher, preceptor and thesis supervisor.
Dr. Lemieux-Charles’s research focuses on performance management, human resources management, organizational learning, knowledge transfer and service delivery networks – all within the context of healthcare. Some of her ongoing research projects involve the relationship of performance indicators to an organization’s strategic performance; the role of evidence in major system change; and the effectiveness of community-based networks in the delivery of care to individuals with dementia and their caregivers.
Steve Morgan is an Associate Professor in the University of British Columbia’s (UBC) School of Population and Public Health, and an Associate Director of the UBC Centre for Health Services and Policy Research. He has published over 100 articles and reports on pharmaceutical policy issues, and has served as an advisor to governments across Canada and abroad.
The unifying theme of Dr. Morgan’s work is the pursuit of policies that achieve balance between three sometimes competing goals: providing equitable access to necessary care, managing health expenditures, and promoting valued innovation.
As a research scientist Syed is conducting research on childhood cancer in Canada and in developing countries. Currently he is involved in developing international collaborative research on childhood cancer in developing countries, social stigma attached to cancer and public participation in priority setting decision-making process. He has over 20 years’ experiences in health and social research, and health policy analysis. He has expertise in conducting research using both qualitative and quantitative methodologies.
His previous work experience in the London School of Hygiene and Tropical Medicine, University of London, UK focused on health system development, health care financing, and health human resources in low and middle income countries. His other research interests include national and provincial health care policies as they pertain to primary health care, priority setting and resource allocation methodologies and applications, and health technology assessment. Syed has PhD in Health Economies and Health Service Research from the University of London, UK and Masters in Health Management, Planning and Policy from the University of Leeds, UK.
Dr. Sullivan is the former President and Chief Executive Officer of Cancer Care Ontario, a position he occupied for 10 years. From 1993 to 2001, Dr. Sullivan held the position of President of the Institute for Work & Health — a private, not-for-profit Institute affiliated with the University of Toronto, which he developed into North America’s leading research centre on work-related injury. Dr. Sullivan has held senior roles in the Ontario ministries of Health, and Intergovernmental Affairs, and in the Cabinet Office. He served two successive First Ministers of Ontario as Executive Director of the Premier’s Council on Health Strategy, including a period of time as Deputy Minister.
Dr. Sullivan is an active behavioral scientist with research and practice interests in cancer prevention and health system performance.
He holds faculty appointments in the Departments of Health Policy, Management and Evaluation and Public Health Sciences at the University of Toronto. His current voluntary commitments include acting as Vice-Chair of the Ontario Agency for Health Protection and Promotion. Previous Board experience includes the Canadian Partnership Against Cancer, the Canadian Association of Provincial Cancer Agencies, the Ontario Institute for Cancer Research, AllerGen’s Institute for Clinical Evaluative Sciences, and the University Health Network.
Kerynn Wang completed her MPH at the University of Hong Kong and holds an HBSc from the University of Toronto. As a Research Associate with the Cancer Services and Policy Research Unit, Kerynn is assisting the team on various service-directed research projects that examines strategic policy issues to support cancer system decision-makers and broader health policy researchers. Previous work experience focused on exploring the inter-relationships within health services multidisciplinary research teams and analyzing health system interventions. Her research interests include evidence-based impact evaluation in applied health services, as well as strategies to facilitate knowledge exchange within the cancer and health policy systems.